Start free trial

Latest AlzeCure Pharma News & Updates

See the latest news and media coverage for AlzeCure Pharma. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
AlzeCure Pharma

Swedish pharmaceutical company developing neurological disease treatments

alzecurepharma.se
Headquarters
Stockholm, Sweden
Founded year
2016
Company type
Public company
Number of employees
15–50
Industry
Pharmaceuticals

Last updated

Latest news about AlzeCure Pharma

In short: AlzeCure Pharma appointed Johan Sandin acting CEO after $3 billion Lilly and QuantumCell deals

Company announcements

AlzeCure Pharma

AlzeCure Pharma attends Bio Japan 2026

The company will update investors on shifted focus to pain projects ACD137 and ACD440, following Alzheimer project out-licensing.

AlzeCure Pharma

AlzeCure Pharma publishes its first half 2026 interim report with key licensing agreements

The biotech firm secured USD 3 billion in potential deal value from partnerships with Eli Lilly and QuantumCell alongside a fully subscribed capital raise.

Unlock all announcements with a

Media coverage

Privata Affärer

Alzecure Pharma turns to profit

Research company Alzecure Pharma reports a net result of 80.2 million SEK (-9.8) in the second quarter of 2026.

Unlock all articles with a

Never miss news about AlzeCure Pharma

Track AlzeCure Pharma and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

AlzeCure Pharma competitors & trending companies

Browse news for competitors to AlzeCure Pharma and other trending companies.